Treatment of severe atopic dermatitis by topical immune modulation using dinitrochlorobenzene.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 10727322.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We present the results of a small uncontrolled pilot trial which suggest that contact sensitization to dinitrochlorobenzene and repeated weekly applications significantly improve the clinical status of severe atopic dermatitis in adults. Although no changes were noted in circulating levels of either lymphocyte subset populations or the serum cytokines assayed in this trial, our observations may be due to topical immune modulation by dinitrochlorobenzene. Larger controlled studies of dinitrochlorobenzene treatment in atopic dermatitis are warranted.
Medical subject headings
- Dermatitis, Atopic
- Dinitrochlorobenzene